Quality indicators in rheumatoid arthritis care: Using measurement to promote quality improvement

Annals of the Rheumatic Diseases

Volumn 72, Issue SUPPL. 2, 2013, Pages

  Bombardier, Claire ^a,b,c,d   Mian, Samra ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c INSTITUTE FOR WORK AND HEALTH   (Canada)

^d MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; PREDNISONE;

ARTICLE; DISEASE ACTIVITY; DISEASE COURSE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; MEDICAL DECISION MAKING; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; HUMANS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES AS TOPIC; QUALITY IMPROVEMENT; QUALITY INDICATORS, HEALTH CARE; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84876297586     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-202259     Document Type: Article

References (48)

1. Arthritis Alliance of Canada. The Impact of Arthritis in Canada: Today and over the Next 30 Years. 2011. http://www.arthritisnetwork.ca/downloads/ 20111022-Impact-of-arthritis.pdf (accessed 20 Jul 2012).
2. Grol R. Successes and failures in the implementation of evidence-based guidelines for clinical practice. Med Care 2001;39(8 Suppl. 2):46-54.
3. Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients' care. Lancet 2003;362:I225-30.
4. Committee on Quality of Health Care in America, Institute of Medicine. To err is human: building a safer health system. Washington, DC: National Academy Press, 1999.
5. Committee on Quality of Health Care in America, Institute of Medicine. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academy Press, 2001.
6. Jamal S, Alibhai SM, Badley EM, et al. Time to treatment for new patients with rheumatoid arthritis in a major metropolitan city. J Rheumatol 2011;38:1282-8.
7. MacLean CH, Saag KG, Solomon DH, et al. Measuring quality in arthritis care: methods for developing the Arthritis Foundation's quality indicator set. Arthritis Rheum 2004;51:193-202. (Pubitemid 38468701)
8. MacLean CH, Louie R, Leake B, et al. Quality of care for patients with rheumatoid arthritis. JAMA 2000;284:984-92. (Pubitemid 30662053)
9. Lacaille D, Anis AH, Guh DP, et al. Gaps in care for rheumatoid arthritis: a population study. Arthritis Rheum 2005;53:241-8. (Pubitemid 40530165)
10. Myasoedova E, Crowson CS, Kremers HM, et al. Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum 2010;62:1576-82.
11. Gabriel SE, Crowson CS, Campion ME, et al. Indirect and nonmedical costs among people with rheumatoid arthritis and osteoarthritis compared with nonarthritic controls. J Rheumatol 1997;24:43-8. (Pubitemid 27059856)
12. Maetzel A, Li LC, Pencharz J, et al. The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study. Ann Rheum Dis 2004;63:395-401. (Pubitemid 38453305)
13. Institute of Medicine. Improving information services for health services researchers: a report to the National Library of Medicine. Washington, DC: National Academy Press, 1991.
14. Cohen S, Gabriel S, Moynihan E. The quality movement-rheumatologists need to be prepared. Arthritis Care Res (Hoboken) 2006;1:1-12.
15. Grimshaw JM, Russell Ian T. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993;342:1317-22. (Pubitemid 23345178)
16. McCabe C, Kirchner C, Zhang H, et al. Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules. Arch Intern Med 2009;169:1525-31.
17. Arnold FW, LaJoie AS, Brock GN, et al. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results. Arch Intern Med 2009;169:1515-24.
18. Donabedian A. The end result of health care: Ernest Codman's contribution to quality assessment and beyond. Milbank Quarterly 1989;67:233-56. (Pubitemid 20278770)
19. Chassin MR, Loeb JM, Schmaltz SP, et al. Accountability measures-using measurement to promote quality improvement. N Engl J Med 2010;363:683-8.
20. Kieft CI, Allison JJ, Williams OD, et al. Improving quality improvement using achievable benchmarks for physician feedback: a randomized controlled trial. JAMA 2001;285:2871-9. (Pubitemid 32537351)
21. Berwick DM. Continuous improvement as an ideal in health care. N Engl J Med 1989;320:53-6. (Pubitemid 19033064)
22. Donabedian A. The quality of care. How can it be assessed? JAMA 1988;260:1743-8.
23. MacLean CH, Louie R, Leake B, et al. Quality of care for patients with rheumatoid arthritis. JAMA 2000;284:984-92. (Pubitemid 30662053)
24. Hazlewood G, Schieir O, Akhavan P et al. A systematic review and quality appraisal of guidelines on the pharmacological treatment of rheumatoid arthritis. Ann Rheum Dis 2010;69(Suppl. 3):479.
25. Scottish Intercollegiate Guidelines Network (SIGN). Management of early rheumatoid arthritis. SIGN Publication 2000;48. http://www.sign.ac.uk/ guidelines/fulltext/48/index.html (accessed 14 Jun 2012).
26. Luqmani R, Hennell S, Estrach C, et al. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years). Rheumatology 2009;48:436-9.
27. Australian Rheumatology Association (ARA). Updated recommendations for the use of biological agents for the treatment of rheumatic diseases. 2010. http://www.rheumatology.org.au/otherpages/biological-guidelines.asp (accessed 25 Feb. 2012).
28. National Institute for Health and Clinical Excellence (NICE). Rheumatoid arthritis: the management of rheumatoid arthritis in adults: NICE clinical guidance. London: NICE, 2009;79.
29. Saag KG, Teng GG, Patkar NM, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Care Res 2008;59:762-84. (Pubitemid 351847559)
30. Smolen JS, Landewe R, Breedveld FC, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010;69:964-75.
31. Bykerk VP, Akhavan P, Hazlewood GS, et al. Canadian Rheumatology Association Recommendations for Phamacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs Canadian. J Rheumatol vol. 39 no 8 1559-158 Published Online First: 2011a Sep 2011. doi:10. 3899/jrheum.110207
32. Bombardier C, Hazlewood GS, Akhavan P, et al. Canadian Rheumatology Association Recommendations for Phamacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs: Part II Safety. J Rheumatol 2012 Aug; 39(8): 1583-602 Published Online First: 2012 Jun 15. doi:10.3899/jrheum.120165
33. Fervers B, Burgers JS, Haugh MC, et al. Adaptation of clinical guidelines: literature review and proposition for a framework and procedure. Int J Qual Health Care 2006;18:167-76. (Pubitemid 43997301)
34. AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care 2003;12:18-23.
35. Saag KG, Yazdany J, Alexander C, et al. Defining quality of care in rheumatology: the American College of Rheumatology white paper on quality measurement. Arthritis Care Res (Hoboken) 2011;63:2-9.
36. Tavares R, Pope JE, Tremblay JL, et al. Early management of newly diagnosed rheumatoid arthritis by Canadian rheumatologists: a national, multicenter, retrospective cohort. J Rheumatol 2011;38:2342-5.
37. Adhikesavan LG, Newman ED, Diehl MP, et al. American College of Rheumatology quality indicators for rheumatoid arthritis: benchmarking, variability, and opportunities to improve quality of care using the electronic health record. Arthritis Rheum 2008;59:1705-12.
38. Fabian LA, Geppert J. Quality indicator measure development, implementation, maintenance, and retirement summary. Rockville, MD: Agency for Healthcare Research and Quality, 2011:1-11.
39. Desai SP, Yazdany J. Quality measurement and improvement in rheumatology. Arthritis Rheum 2011;63:3649-60.
40. Mant J. Process versus outcome indicators in the assessment of quality of health care. Int J Qual Health Care 2001; V13, 6:475-80. (Pubitemid 33133922)
41. Khanna D, Arnold E, Pencharz JN, et al. Measuring process of arthritis care: the arthritis foundation's quality indicator set for rheumatoid arthritis. Semin Arthritis Rheum 2006;35:211-37. (Pubitemid 43185213)
42. van Hulst LTC, Fransen J, den Broeder AA, et al. Development of quality indicators for monitoring of the disease course in Rheumatoid Arthritis. Ann Rheum Dis 2009;68:1805-10.
43. Schmajuk G, Trivedi AN, Solomon DH, et al. Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in medicare managed care plans. JAMA 2011;305:480-6.
44. Kahn KL, Maclean CH, Wong AL, et al. Assessment of American College of Rheumatology quality criteria for rheumatoid arthritis in a pre-quality criteria patient cohort. Arthritis Rheum 2007;57:707-15. (Pubitemid 46932074)
45. American College of Rheumatology. Rheumatoid arthritis quality indicators. http://www.rheumatology.org/practice/clinical/quality/RA.asp (accessed 15 Jun 2012).
46. Solomon DH, Gabriel SE. Moving forward qith quality: pay for reporting meets rheumatology. Arthritis Rheum 2007;57:703-4. (Pubitemid 46932072)
47. Epstein AM. Paying for performance in the United States and abroad (editorial). N Engl J Med 2006;355:406-8. (Pubitemid 44127545)
48. Solomon DH, Gabriel SE. Moving forward with quality: pay for reporting meets rheumatology. Arthritis Rheum 2007;57:703-4. (Pubitemid 46932072)